Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cefiderocol, sold under the brand name Fetroja (by Shionogi) among others, is an antibiotic used to treat complicated urinary tract infections when no other options are available. It is indicated for the treatment of multi-drug-resistant Gram-negative bacteria including Pseudomonas aeruginosa. It is given by injection into a vein.
History & Applications
Explore the main themes, entities and connections around Cefiderocol. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
infections treatment gram-negative drug complicated urinary tract bacteria 2020 participants including caused antibiotic options european infusion fetroja iron trial indicated
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cefiderocol | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cefiderocol | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Cefiderocol | ATC code | J01DI04 (WHO) | 1.00 | infobox |
| Cefiderocol | CAS Number | 1225208-94-5 | 1.00 | infobox |
| Cefiderocol | ChEBI | CHEBI:140376 | 1.00 | infobox |
| Cefiderocol | ChEMBL | ChEMBL3989974 | 1.00 | infobox |
| Cefiderocol | ChemSpider | 52084902 | 1.00 | infobox |
| Cefiderocol | CompTox Dashboard (EPA) | DTXSID401098052 | 1.00 | infobox |
| Cefiderocol | Drug class | Siderophore cephalosporins | 1.00 | infobox |
| Cefiderocol | DrugBank | DB14879 | 1.00 | infobox |
| Cefiderocol | Elimination half-life | 2.8 hours | 1.00 | infobox |
| Cefiderocol | Excretion | mainly kidney (60–70% unchanged) | 1.00 | infobox |
| Cefiderocol | Formula | C30H34ClN7O10S2 | 1.00 | infobox |
| Cefiderocol | KEGG | D11013 | 1.00 | infobox |
| Cefiderocol | KEGG | D11302 | 1.00 | infobox |
| Cefiderocol | Legal status | US: ℞-only | 1.00 | infobox |
| Cefiderocol | Legal status | EU: Rx-only | 1.00 | infobox |
| Cefiderocol | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Cefiderocol | License data | EU EMA: by INN | 1.00 | infobox |
| Cefiderocol | License data | US DailyMed: Cefiderocol_sulfate_tosylate | 1.00 | infobox |
| Cefiderocol | MedlinePlus | a620008 | 1.00 | infobox |
| Cefiderocol | Molar mass | 752.21 g·mol−1 | 1.00 | infobox |
| Cefiderocol | Other names | RSC-649266 | 1.00 | infobox |
| Cefiderocol | Protein binding | 56–58% | 1.00 | infobox |
| Cefiderocol | PubChem CID | 77843966 | 1.00 | infobox |
| Cefiderocol | Routes of administration | Intravenous infusion | 1.00 | infobox |
| Cefiderocol | Trade names | Fetroja, Fetcroja | 1.00 | infobox |
| Cefiderocol | UNII | SZ34OMG6E8 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.